Search
  • Search


    Reagents for analysis of genetic markers in human DNA

    HUS-yhtymä

    Reagents for analysis of genetic markers in human DNA

    1. Competition notice published

      Jul 9, 2025 5:09 AMJuly 9, 2025 5:09 AM
    2. Contract signed

      Nov 28, 2025 12:00 AMNovember 28, 2025 12:00 AM
    3. Result notice published

      Dec 2, 2025 11:23 AMDecember 2, 2025 11:23 AM

    Brief

    Finland: Tenders/HUS-yhtymä/Reagents for analysis of genetic markers in human DNA

    Awarded

    The competition has ended and a winner has been selected.

    Deadline
    Dec 1, 2025Expired
    Award
    Quality 50%
    Procedure
    OpenSingle stage
    Agreement
    Buying goodsover 4 years

    Brief

    HUS-yhtymä on tehnyt sopimuksen AH Diagnostics Oy:n kanssa reagenssien toimittamisesta geneettisten markkereiden analysointiin ihmisen DNA:sta. Toimituspaikka on HUSin (Helsingin yliopistollisen sairaalan) diagnostisen keskuksen genetiikan laboratorio. Sopimuksen kesto on 4 vuotta, ja sen arvo on 250 000 euroa. Reagenssien on oltava yhteensopivia Tecan- ja Hamilton-pipetointirobottien sekä Thermo ABI QuantStudio -sarjan ja Roche LightCycler -sarjan Real-Time PCR -syklerien kanssa. Vuosittainen testausmäärä on arviolta 50 000 reaktiota vuodessa. Kilpailuun osallistui 4 tarjoajaa.

    Laboratorie- og analyseutstyr

    Result

    • AH Diagnostics Oy
      Winner
    • Number of bids
      4
    • Contract value
      €250,000

    Custom Assessment Criteria

    • Get answers to your bid/no-bid criteria

      Set them up once and Cobrief answers them in every tender

    Will you bid?

    The agent sets up the bid and writes the first draft. Free for 14 days.

    Award Criteria

    • Description

      The tender with the lowest price will be given the full 50 points (the same as the weighting of the price), and the other tenders will be given points in proportion to the lowest price using the formula: lowest price/comparison price x weighting of price (50). The tenderer shall provide their tender price in the section "Procurement Object Criteria".

      Evaluation Method

      The tender with the lowest price will be given the full 50 points. The other tenders will be given points in proportion to the lowest price.

      Source

      No source found in the documents. Check the weight against the tender documents.

    • Description

      The quality (50 points) is assessed based on the submitted tenders. The quality is scored based on the trial use. The quality comparison is described in the annex 10 "Test procedure for qPCR mastermix".

      Evaluation Method

      The tender with the highest quality scores will be given the full 50 points. The other tenders will be given points using the formula: tenderer´s quality score/highest quality score x 50.

      Source

      No source found in the documents. Check the weight against the tender documents.

    Previous winners

    • Who are you up against?

      The suppliers who have won similar contracts at HUS-yhtymä

    From the notice

    • Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is an SFS-EN ISO 15189:2022 accredited laboratory providing diagnostic genetic testing services to all patients at Helsinki University Hospital area. The services include analysis of both constitutional samples and malignancies using multiple automated diagnostic laboratory processes. Currently Laboratory of Genetics is seeking for a Mastermix / Supermix reagent used in large scale testing using quantitative PCR. The process is a LDT process. The sample material in most cases is DNA isolated from EDTA-blood samples. The product may also be used to quantify cDNA targets prepared from RNA isolated from CPT blood samples. The reagents offered must be compatible with pipetting using Tecan and Hamilton pipetting robots and amplification/analysis using Thermo ABI QuantStudio series and Roche LightCycler series Real-Time PCR cyclers. The expected annual test volume is 50 000 reactions / year.Main features of the procedureThe procurement shall comply with the Act on Public Procurement and Concession Contracts (1397/2016, referred to as the Public Procurement Act). The procurement value exceeds the EU threshold value. The procedure shall be an open procedure as defined in section 32 of the Public Procurement Act. PROCESSING OF TENDERS The procedure shall include the following phases: The Procurement authority 1) Opens the tenders 2) Verifies the suitability of the tenderers 3) Verifies the conformance of the tenders to the call for tenders and arrange a trial use 4) Compares the tenders 5) Requests and checks the certificates and statements regarding the suitability of the winning tenderer 6) Makes the procurement decision and informs all tenderers of the decision 7) Makes the agreement with the selected tenderer The Procurement authority may wholly or partially interrupt the procurement procedure for legitimate and justifiable reason (Section 125 of the Act on Public Contracts). No compensation will be paid to companies for participating in the tendering process. LANGUAGE OF THE PROCUREMENT PROCEDURE The procurement documents are available in English. If the tenderer needs the documents in another language, the tenderer is responsible for the translation and its costs. Tenders and all attachments to the tender must be drawn up in English. PARALLEL AND ALTERNATIVE TENDERS Submitting parallel and alternative tenders is prohibited. SUBCONTRACTING The tenderer may use subcontractors. The tenderer is responsible for the work of the subcontractor as if it were their own in relation to the client. The client will sign the procurement contract only with the company that submitted the tender. Subcontractors used in the procurement must be named. The following information must be provided for the named subcontractors: The official name and business ID of the subcontractor The role of the subcontractor in the procurement Contact information (including the country, if other than Finland) Information about the subcontractor must be provided in a separate attachment, which will be uploaded as part of the tender. This requirement also applies to resource subcontractors. Named subcontractors are considered the tenderer's resources. Therefore, the tenderer must commit to ensuring that the named subcontractors in the tender are available for the execution of the procurement if the tenderer is selected. The Procurement authority may require a security clearance, as defined by the Security Clearance Act, for the The Procurement authority's and the The Procurement authority's subcontractors’ personnel, as stated in the contract terms. The winning tenderer must provide certificates and reports about the subcontractors participating as requested, as required in the call for tender, before signing the contract.

    • Contact

      Diagnostiikka-kategoriakilpailutus.diagnostiikka@hus.fi
    • Type
      Result
    • Main code
      Laboratory reagents
      33696500

    Similar active competitions

    • HUS-yhtymä

      Laboratorie- og analyseutstyr

      MLPA-Based CNV Testing for BRCA1/BRCA2

      HUS Group, the joint authority for Helsinki and Uusimaa, needs an MLPA (Multiplex Ligation-dependent Probe Amplification) assay for the detection of copy number variations (CNVs) in BRCA1 and BRCA2 genes, including all reagents, controls, consumables, software, licenses, and other components required for routine use and generation of reportable patient results. The contract period is 2 years, after which it continues indefinitely until terminated. The estimated annual consumption is approximately 1600 reportable patient samples, to be delivered to the HUSLAB Laboratory of Genetics in Helsinki-Uusimaa, Finland. The award criterion is the lowest total comparison price.

      Competition
      Nov 9, 2026(11 days)
    • HUS-yhtymä

      Helse- og sosial tjenesteyting

      HUS Subcontracting genetic diagnostic tests

      HUS Group needs genetic diagnostic test services to support clinical patient work and individual patient treatment decisions. These services are for various clinics within the HUS Joint Municipal Authority for Specialised Health Care, and also for ISLAB (Eastern Finland Laboratory Centre, Joint Authority Enterprise). The services are procured through a dynamic purchasing system. Suppliers must have a yearly turnover of at least EUR 500,000, a risk category of RL1-RL3, professional experience with similar genetic diagnostic test services for reference customers during the last three years, and the laboratory must have accreditation status secured for at least two years. Additionally, candidates must have experience in supplying at least 5000 genetic studies yearly for university-level or similar hospitals within the EU/EEA area. Award criteria for specific competitions will be based on overall financial affordability, which may include price and/or quality.

      Dynamic purchasing system
      May 9, 2030(100+ days)
    • HUS-yhtymä

      Medisinsk og laboratorieutstyr

      REQUEST FOR INFORMATION: SPRI Beads

      HUS-yhtymä is planning the procurement of DNA size selection reagents based on paramagnetic beads, utilizing SPRI technology for selective binding and purification of DNA fragments, to be used in next-generation sequencing (NGS) library preparation. Suppliers can provide feedback and input by submitting a response via email to kilpailutus.diagnostiikka@hus.fi, addressing all requirements, providing requested information and documentation, and identifying any concerns or proposed amendments to the draft agreement.

      Planning
      Nov 1, 2026(3 days)